KURIYEL RALF (Senior VP, R&D) sold 18.8% of their position (4.46K shares) of REPLIGEN CORP on the open market
Open‑market sale worth $739.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/1/2024ACC: 0000950170-24-089553
-4.46K
Net shares
Net seller
$739.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.46K
Price / share
$165.67
Trade value
$739.72K
% of position
18.8%
8/1/2024
23.73K→19.26K
Total
Net shares
−4.46K
Net value
-$739.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2024 | S · Sale | −4.46K | $165.67 | $739.72K | 18.8% | 23.73K | 19.26K |
| Total | −4.46K | -$739.72K | ||||||
Derivative Transactions0
No derivative transactions reported